HealthStream (NASDAQ:HSTM) EVP Kevin O’hara Sells 4,000 Shares of Company Stock

HealthStream, Inc. (NASDAQ:HSTM) EVP Kevin O’hara sold 4,000 shares of the firm’s stock in a transaction on Thursday, November 5th. The stock was sold at an average price of $31.11, for a total transaction of $124,440.00. Following the completion of the sale, the executive vice president owned 18,901 shares in the company, valued at $588,010.11. This represents a 17.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

HealthStream Stock Performance

Shares of NASDAQ:HSTM traded down $0.71 on Friday, hitting $28.89. 249,732 shares of the company were exchanged, compared to its average volume of 188,233. The company’s 50 day moving average price is $31.20 and its two-hundred day moving average price is $25.83. The firm has a market capitalization of $844.17 million, a price-to-earnings ratio of 41.27, a PEG ratio of 4.00 and a beta of 0.45. HealthStream, Inc. has a one year low of $19.50 and a one year high of $35.60.

HealthStream (NASDAQ:HSTM) last released its earnings results on Monday, November 2nd. The technology company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.02. HealthStream had a net margin of 6.25% and a return on equity of 6.58%. The business had revenue of $83.31 million during the quarter, compared to analysts’ expectations of $82.24 million. Research analysts predict that HealthStream, Inc. will post 0.80 earnings per share for the current year.

HealthStream Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Monday, November 16th will be given a $0.0350 dividend. The ex-dividend date is Monday, November 16th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.5%. HealthStream’s dividend payout ratio (DPR) is currently 20.00%.

Hedge Funds Weigh In On HealthStream

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Arrowstreet Capital Limited Partnership grew its position in HealthStream by 21.1% in the first quarter. Arrowstreet Capital Limited Partnership now owns 377,945 shares of the technology company’s stock valued at $7,827,000 after acquiring an additional 65,806 shares during the period. Quantinno Capital Management LP raised its stake in HealthStream by 283.5% during the first quarter. Quantinno Capital Management LP now owns 50,169 shares of the technology company’s stock worth $1,039,000 after acquiring an additional 37,088 shares in the last quarter. Lazard Asset Management LLC lifted its holdings in shares of HealthStream by 268.2% during the first quarter. Lazard Asset Management LLC now owns 157,208 shares of the technology company’s stock valued at $3,256,000 after acquiring an additional 114,511 shares during the period. Bank of New York Mellon Corp bought a new position in shares of HealthStream during the second quarter valued at $6,199,000. Finally, Legal & General Group Plc acquired a new stake in shares of HealthStream in the 2nd quarter valued at $1,588,000. Institutional investors own 69.58% of the company’s stock.

Key Headlines Impacting HealthStream

Here are the key news stories impacting HealthStream this week:

• Positive Sentiment: Buy rating upgrade: Zacks upgraded HSTM to Rank #2 (Buy), citing improving earnings prospects, which could support investor optimism. Zacks article
• Positive Sentiment: Raised guidance: HealthStream lifted its outlook, a potentially positive sign for expected business performance, although the article raises the question of whether prior gains already reflect the news. Yahoo Finance article
• Neutral Sentiment: Analyst views remain cautious: Canaccord Genuity raised its price target to $32 from $29 but maintained a Hold rating; Craig Hallum also moved its rating to Hold. These calls suggest limited conviction despite the higher target. Canaccord rating information Craig Hallum rating article
• Negative Sentiment: Multiple insider sales: On November 5, EVP Michael Manning Collier, CFO Scott Alexander Roberts, Director Deborah Tate and EVP Kevin O’Hara sold a combined 38,081 shares. Each reduced their individual holdings, a cluster of transactions that may weigh on sentiment, though insider sales alone do not establish a change in the company’s outlook. Collier SEC filing Roberts SEC filing Tate SEC filing O’Hara SEC filing

Analyst Ratings Changes

A number of research firms have recently issued reports on HSTM. Canaccord Genuity Group boosted their price objective on HealthStream from $29.00 to $32.00 and gave the company a “hold” rating in a research report on Wednesday. Freedom Capital raised HealthStream to a “hold” rating in a research report on Tuesday, October 13th. Weiss Ratings upgraded shares of HealthStream from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, October 8th. Craig Hallum downgraded shares of HealthStream from a “buy” rating to a “hold” rating and set a $40.00 price target on the stock. in a research note on Tuesday. Finally, Citigroup reissued a “market perform” rating on shares of HealthStream in a report on Tuesday, October 27th. One investment analyst has rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, HealthStream presently has a consensus rating of “Hold” and a consensus target price of $36.00.

About HealthStream

HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its software and services help hospitals, health systems, medical practices and other healthcare providers manage employee education, training, credentialing, compliance and professional development.

The company’s offerings include learning management and education tools, competency and performance-management solutions, and systems for managing provider credentials, privileging and enrollment.